The Lung Cancer Working Group (LCWG) is a team of experts in various fields who specialize in thoracic malignancies in Armenia. This multidisciplinary team consists of medical oncologists, radiation oncologists, thoracic surgeons, pathologists, and radiologists, who convene bi-weekly to discuss the management strategy for patients diagnosed with thoracic malignancies such as lung cancers, mesotheliomas, thymic carcinomas, or thymomas. The primary objective of these meetings is to enhance the quality of medical care provided to patients suffering from these conditions, while also promoting knowledge sharing and improved communication within the local medical community. The group also engages in clinical and public health research in the field of thoracic oncology, and has taken on the vital task of adapting international guidelines for the management of thoracic malignancies to the Armenian language and context.
Professor Gregory Peter Kalamkerian supervises and mentors the working group. Dr. Kalemkerian is a Professor of Medicine at the University of Michigan's Division of Hematology/Oncology, where he serves as the Associate Division Chief for Faculty Development and Education, Associate Director of the Hematology/Oncology Fellowship Program, and Co-Director of the Thoracic Oncology Clinical Research Team. He is also the former chair of the NCCN Small Cell Lung Cancer Guideline Panel, and treats patients with lung cancer, thymoma, and mesothelioma. Dr. Kalemkerian is a recipient of several awards, including the ASCO Excellence in Teaching Award and the University of Michigan Outstanding Clinician Award. He has authored numerous research articles, reviews, commentaries, and book chapters.
Dr. Davit Zohrabyan serves as the co-chairman of the Lung Cancer Working Group. He is the Chairman of the Chemotherapy Clinic of Solid Tumors at the Hematology Center named after Prof. R. Yeolyan and a faculty member at the Department of Oncology of Yerevan State Medical University. Dr. Zohrabyan co-founded the City of Smile Charitable Foundation, which fully covers the diagnosis and treatment costs for cancer patients in Armenia up to the age of 25, and the Armenian Association of Hematology and Oncology, which creates professional development opportunities for cancer care providers in Armenia and engages in awareness-raising programs. He has multiple peer-reviewed publications and has presented his research in various international events. Dr. Zohrabyan is a member of the European Society for Medical Oncology National Societies Committee and the American Cancer Society’s International Education Steering Committee, and is currently working on and supervising several research projects in oncology and public health.
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.